Metastatic symptoms include: Taking a low dose of Xeloda (capecitabine)—a chemotherapy drug—for one year after surgery to remove early-stage triple-negative breast cancer plus standard ...

A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes similar to the current standard of care, a clinical trial co-led by a UT ...

Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks estrogen, progesterone, and HER2 ...

Triple-negative breast cancer is mainly treated with chemotherapy ... It may have tiny dimples, puckers, or ridges that make it look like the skin of an orange. Symptoms can look like an infection.

The basal-like subtype of breast cancer, which consists mainly of 'triple-negative' breast cancers (i.e. tumors negative for the estrogen receptor [ER], progesterone receptor [PR] and HER2), is ...

Atezolizumab (Tecentriq) plus chemotherapy after surgery did not improve survival in high-risk triple-negative breast cancer, ...

The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain lesions, might be warranted, reported Kamran Ahmed, MD, of Moffitt Cancer Center ...

Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune response, according to updated results of a phase 1 trial. Injection site ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the significance of triple-negative breast cancer research in the Asia-Pacific region, and the importance of clinical trial ...